FIELD: medicine.
SUBSTANCE: invention relates to medicine and biochemistry and applies to combined pharmaceutical preparation, which contains G-CSF and PIGF as active substances.
EFFECT: invention ensures synergic effect in mobilisation of stem blood cells of patient or of individual who needs it.
10 cl, 11 ex, 11 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITION AND METHOD FOR ELEVATING AMOUNT OF STEM CELLS AND/OR HEMOPOIETIC CELL-PRECURSORS IN CIRCULATION IN PERIPHERAL BLOOD OF MAMMALS | 2001 |
|
RU2248216C2 |
| METHOD FOR PREDICTION OF HEMATOPOIETIC STEM CELL COLLECTION EFFICIENCY | 2023 |
|
RU2821227C1 |
| METHOD FOR OBTAINING OF MSC-ASSOCIATED NON-DIFFERENTIATED HEMOPOIETIC PRECURSOR CELLS WITH CD34+/CD133+ PHENOTYPE | 2016 |
|
RU2628092C1 |
| METHOD FOR CARRYING OUT EXPERIMENTAL MYOCARDIAL INFARCTION THERAPY | 2005 |
|
RU2288738C2 |
| STEM CELL THERAPY IN ENDOMETRIAL PATHOLOGIES | 2015 |
|
RU2725006C2 |
| METHOD FOR CARRYING OUT EXPERIMENTAL ENCEPHALOPATHY THERAPY | 2004 |
|
RU2284060C1 |
| METHOD FOR TREATING EXPERIMENTAL CHRONIC TOXIC HEPATITIS | 2005 |
|
RU2295971C1 |
| EXPERIMENTAL TOXIC CHRONIC HEPATITIS TREATMENT METHOD | 2009 |
|
RU2392000C1 |
| PHARMACEUTICAL COMPOSITION CONTAINING C-KIT-LIGAND AND HEMOPOIETIC FACTOR, METHOD OF ENHANCEMENT OF PERIPHERAL BLOOD STEM CELL LEVELS, ANTAGONIST OF C-KIT-LIGAND, ANTISENSE MOLECULE OF NUCLEIC ACID, METHOD OF ENHANCEMENT OF PERIPHERAL BLOOD CELL LEVELS EX-VIVO | 1993 |
|
RU2180850C2 |
| METHODS FOR ACTIVATION OF CELLS-PRECURSORS/STEM CELLS | 2002 |
|
RU2309741C2 |
